Medical writing bias in myeloma clinical research [Video]

James Berenson, MD, Berenson Cancer Center, West Hollywood, CA, speaks on a study examining medical write-ups of multiple myeloma (MM) clinical trials conducted since 2000. The analysis revealed a significant rise in papers authored by individuals employed by drug companies, reaching nearly 50% in 2023, indicating a potential bias in the literature. This interview took place at the 65th ASH Annual Meeting and Exposition, held in San Diego, CA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.